Table II.
Laboratory values and treatment characteristics for patients with coronavirus disease 2019 (COVID-19)
No COVID-19 or not tested | COVID-19 positive | P value | |
---|---|---|---|
No. | 25 | 15 | |
WBC, k/μL | 9.9 [8.0-13.1] | 14.5 [8.7-16.7] | .208 |
Neutrophil count, k/μL | 7.6 [5.5-12.3] | 12.3 [5.5-15.1] | .253 |
Lymphocyte count, k/μL | 1.5 [1.2-2.1] | 1.1 [0.8-1.7] | .079 |
Monocyte count, k/μL | 0.8 [0.6-1.0] | 0.7 [0.5-0.8] | .316 |
Eosinophil count, k/μL | 0.2 [0.1-0.2] | 0.1 [0.0-0.1] | .032 |
Neutrophil to lymphocyte ratio | 4.6 [2.2-7.3] | 10.1 [4.4-23.6] | .084 |
Hemoglobin, g/dL | 11.6 [9.0-12.5] | 12.3 [10.8-14.1] | .203 |
Platelet Count, k/μL | 261.0 [192.0-331.0] | 295.5 [170.5-318.0] | .884 |
Prothrombin time, seconds | 15.2 [14.3-17.1] | 15.9 [14.7-20.8] | .368 |
aPTT, seconds | 33.1 [29.5-45.7] | 39.1 [32.0-47.4] | .400 |
Total bilirubin, mg/dL | 0.4 [0.3-0.8] | 0.6 [0.3-1.3] | .341 |
SCr at admission, mg/dL | 1.05 [0.86-1.62] | 1.18 [0.77-1.35] | .665 |
SCr at time of duplex, mg/dL | 1.01 [0.83-1.35] | 1.30 [0.90-2.04] | .247 |
Troponin, ng/mL | 0.01 [0.01-0.04] | 0.01 [0.01-0.09] | .718 |
d-Dimer at time of diagnosis, μg/mL | 1.8 [1.1-2.7] | 17.3 [5.5-20.0] | .038 |
Average in-hospital d-dimer, μg/mL | 2.0 [1.5-2.7] | 8.5 [3.5-17.1] | .043 |
CRP | 13.8 [9.5-21.6] | 24.2 [9.7-28.1] | .627 |
CPK | 144.5 [75.5-524.0] | 359.0 [195.0-523.0] | .667 |
Ferritin | 412.0 [296.5-704.0] | 974.0 [293.5-1311.0] | .470 |
Fibrinogen | 653.0 [511.0-691.3] | 488.0 [386.0-653.0] | .628 |
LDH | 338.0 [272.0-512.5] | 576.5 [454.8-744.3] | .313 |
aPTT, Activated partial thromboplastin time; CPK, creatine phosphokinase; CRP, C-reactive protein; LDH, lactate dehydrogenase; SCr, serum creatinine; WBC, white blood cell.
Values are median [interquartile range] unless otherwise indicated. Boldface entries indicate statistical significance.